Ginecología Oncológica & Enfermedades Mamarias - Dr. Carlos Urrutia Romero

  • Casa
  • Peru
  • Pueblo Libre
  • Ginecología Oncológica & Enfermedades Mamarias - Dr. Carlos Urrutia Romero

Ginecología Oncológica & Enfermedades Mamarias - Dr. Carlos Urrutia Romero Médico especialista en la prevención diagnóstico y tratamiento enfermedades Oncológicas ginecológicas

28/01/2026

EDITOR'S PICK: Article of the Month!

"For patients with uterine cancer, comorbidity prevalence and comorbidity index scores varied significantly by race and ethnicity and were highest among non-Hispanic Black patients. Quantifying the distribution of comorbidities allows us to anticipate, statistically, how the accrual of racially minoritized populations may be hampered by individual comorbidity eligibility criteria. We suggest that quantified measures be used to plan both trial eligibility criteria and targeted recruitment in the setting of known eligibility disparities. Strategically planned and culturally appropriate equity efforts are important in today’s cancer care landscape due to funding and policy changes that influence diversity and inclusion efforts."

Listen to Dr. Oluloro explain her team's findings on the Green Room podcast wherever you find your other favorite podcasts, or at: https://journals.lww.com/greenjournal/pages/podcastepisodes.aspx?podcastid=9

Full-length article available to read for FREE at: https://journals.lww.com/greenjournal/fulltext/2026/02000/association_between_comorbidity_and_clinical_trial.15.aspx?context=featuredarticles&collectionid=5

15/01/2026

🔊 infection is extremely common, yet the stigmas around sexual health and cancer persist. Fear, shame, ignorance can cause delays in seeking care and late diagnosis. No one should suffer because of a lack of understanding. Share these facts.

Learn more here: https://igcs.org/cervical-cancer-elimination/

15/01/2026

The : Levonorgestrel-releasing IUD as single therapy for inoperable, early stage and

💡 https://bit.ly/3NbMavU

06/01/2026


ctDNA 🧬 emerges as a promising non-invasive biomarker🔬for detection, with strong performance in early-stage disease.

✴️ A step forward beyond CA125?

💡 https://bit.ly/49osPPp

28/12/2025

Discover the Oncofertility special section in the IJGO, focused on oncofertility cryopreservation—a critical and growing field that bridges oncology and reproductive medicine.

This new collection of papers, curated by FIGO Committee on Reproductive Medicine, Endocrinology and Infertility, sets out best clinical practice guidance for preserving fertility in patients diagnosed with cancer, especially during their reproductive years.

Read more: https://www.figo.org/news/figo-launches-oncofertility-best-practices-preserving-fertility-cancer-patients-0

20/12/2025

MIS vs. Open Surgery for recurrent 🏥

✅ Feasible: 97.3% complete resection rate with MIS.
✅ Gentler: Less blood loss & faster recovery time.
✅ Safe: Survival rates were comparable to open surgery.

📌 https://bit.ly/4oVvQwv

16/12/2025

Las autoridades sanitarias de Estados Unidos han ampliado la aprobación de un fármaco muy debatido destinado a aumentar la libido femenina, tras afirmar que la píldora que se toma una vez al día ahora puede ser tomada por mujeres mayores de 65 años.

16/12/2025

Among women aged 40 to 74 years without a history of , criteria-independent genetic testing in the WISDOM trial detected pathogenic or likely pathogenic variants in 3.1% of participants.

Approximately 30% of women carrying variants in high-penetrance or moderate-penetrance breast cancer susceptibility genes did not report common family history risk factors such as affected relatives or Jewish ancestry.

These results indicate that broader access to genetic testing could identify more individuals eligible for enhanced surveillance and risk-reducing interventions, beyond those identified by guideline-based family history criteria.



https://ja.ma/3MpThR3

15/12/2025
15/12/2025

💗 Encontraste un bultito y tu mente se aceleró… respira tranquila. No te asustes, actúa: busca información, agenda una revisión y recuerda que ir al médico no es para asustarte, sino para cuidarte 🌷

👒 Reserva tu cita:
📞 (01) 204-0404
📱 993 765 019
📌 Av. Nicolás de Piérola 727, Cercado de Lima
📌 Av. Brasil 2746, Pueblo Libre

15/12/2025

AJOG Expert Review: Uterine fibroids at single-cell resolution: unveiling cellular heterogeneity to improve understanding of pathogenesis and guide future therapies - Classification of fibroids https://ow.ly/kGnk50XJ604

15/12/2025

Dirección

Avenida Brasil 271 , Edificio Qualis , Consultorio 922
Pueblo Libre
051

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Ginecología Oncológica & Enfermedades Mamarias - Dr. Carlos Urrutia Romero publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a Ginecología Oncológica & Enfermedades Mamarias - Dr. Carlos Urrutia Romero:

Compartir

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Categoría